These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

318 related articles for article (PubMed ID: 34836059)

  • 1. Nutrient Effects on Motor Neurons and the Risk of Amyotrophic Lateral Sclerosis.
    Goncharova PS; Davydova TK; Popova TE; Novitsky MA; Petrova MM; Gavrilyuk OA; Al-Zamil M; Zhukova NG; Nasyrova RF; Shnayder NA
    Nutrients; 2021 Oct; 13(11):. PubMed ID: 34836059
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Motor neuron dysfunction in a mouse model of ALS: gender-dependent effect of P2X7 antagonism.
    Cervetto C; Frattaroli D; Maura G; Marcoli M
    Toxicology; 2013 Sep; 311(1-2):69-77. PubMed ID: 23583883
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanisms for neuronal degeneration in amyotrophic lateral sclerosis and in models of motor neuron death (Review).
    Martin LJ; Price AC; Kaiser A; Shaikh AY; Liu Z
    Int J Mol Med; 2000 Jan; 5(1):3-13. PubMed ID: 10601567
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Consideration of gravity as a possible etiological factor in amyotrophic lateral sclerosis.
    Akaishi T; Takahashi T; Abe M; Aoki M; Ishii T
    Med Hypotheses; 2019 Nov; 132():109369. PubMed ID: 31442918
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Guanabenz delays the onset of disease symptoms, extends lifespan, improves motor performance and attenuates motor neuron loss in the SOD1 G93A mouse model of amyotrophic lateral sclerosis.
    Jiang HQ; Ren M; Jiang HZ; Wang J; Zhang J; Yin X; Wang SY; Qi Y; Wang XD; Feng HL
    Neuroscience; 2014 Sep; 277():132-8. PubMed ID: 24699224
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The causes and mechanism of selective motor neuron death in amyotrophic lateral sclerosis].
    Van den Bosch L
    Verh K Acad Geneeskd Belg; 2006; 68(4):249-69. PubMed ID: 17214440
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Role of Iron in Amyotrophic Lateral Sclerosis.
    Bu XL; Xiang Y; Guo Y
    Adv Exp Med Biol; 2019; 1173():145-152. PubMed ID: 31456209
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Why do motor neurons degenerate? Actualization in the pathogenesis of amyotrophic lateral sclerosis.
    Riancho J; Gonzalo I; Ruiz-Soto M; Berciano J
    Neurologia (Engl Ed); 2019; 34(1):27-37. PubMed ID: 26853842
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulatory T cells for amyotrophic lateral sclerosis/motor neuron disease: A clinical and preclinical systematic review.
    Rajabinejad M; Ranjbar S; Afshar Hezarkhani L; Salari F; Gorgin Karaji A; Rezaiemanesh A
    J Cell Physiol; 2020 Jun; 235(6):5030-5040. PubMed ID: 31788795
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutant TDP-43 in motor neurons promotes the onset and progression of ALS in rats.
    Huang C; Tong J; Bi F; Zhou H; Xia XG
    J Clin Invest; 2012 Jan; 122(1):107-18. PubMed ID: 22156203
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Development of motor neuron restorative therapy in amyotrophic lateral sclerosis using hepatocyte growth factor].
    Aoki M; Warita H; Suzuki N; Itoyama Y
    Rinsho Shinkeigaku; 2009 Nov; 49(11):814-7. PubMed ID: 20030218
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cross-sectional and longitudinal assessment of the upper cervical spinal cord in motor neuron disease.
    van der Burgh HK; Westeneng HJ; Meier JM; van Es MA; Veldink JH; Hendrikse J; van den Heuvel MP; van den Berg LH
    Neuroimage Clin; 2019; 24():101984. PubMed ID: 31499409
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stem cell-derived motor neurons: applications and challenges in amyotrophic lateral sclerosis.
    Thonhoff JR; Ojeda L; Wu P
    Curr Stem Cell Res Ther; 2009 Sep; 4(3):178-99. PubMed ID: 19492980
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cholinergic modulation of motor neurons through the C-boutons are necessary for the locomotor compensation for severe motor neuron loss during amyotrophic lateral sclerosis disease progression.
    Landoni LM; Myles JR; Wells TL; Mayer WP; Akay T
    Behav Brain Res; 2019 Sep; 369():111914. PubMed ID: 31022419
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolic Abnormalities, Dietary Risk Factors and Nutritional Management in Amyotrophic Lateral Sclerosis.
    D'Amico E; Grosso G; Nieves JW; Zanghì A; Factor-Litvak P; Mitsumoto H
    Nutrients; 2021 Jun; 13(7):. PubMed ID: 34209133
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aberrant regulation of DNA methylation in amyotrophic lateral sclerosis: a new target of disease mechanisms.
    Martin LJ; Wong M
    Neurotherapeutics; 2013 Oct; 10(4):722-33. PubMed ID: 23900692
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exploring Multiple Sclerosis (MS) and Amyotrophic Lateral Scler osis (ALS) as Neurodegenerative Diseases and their Treatments: A Review Study.
    Deeb O; Nabulsi M
    Curr Top Med Chem; 2020; 20(26):2391-2403. PubMed ID: 32972341
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transcranial magnetic stimulation and amyotrophic lateral sclerosis: pathophysiological insights.
    Vucic S; Ziemann U; Eisen A; Hallett M; Kiernan MC
    J Neurol Neurosurg Psychiatry; 2013 Oct; 84(10):1161-70. PubMed ID: 23264687
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cell-based therapies for amyotrophic lateral sclerosis/motor neuron disease.
    Abdul Wahid SF; Law ZK; Ismail NA; Lai NM
    Cochrane Database Syst Rev; 2019 Dec; 12(12):CD011742. PubMed ID: 31853962
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical polymorphism of amyotrophic lateral sclerosis].
    Kovrazhkina EA; Razinskaya OD; Gubsky LV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2017; 117(8):4-10. PubMed ID: 28884711
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.